1. Berek JS. Berek & Novak’s Gynecology, 14th edn. Philadelphia, PA: Lippincott Williams & Wilkins, 2007; 37: 1582–1604.

4. Xue WC, Khoo US, Ngan HY et al. Minichromosome maintenance protein 7 expression in gestational trophoblastic disease: Correlation with Ki67, PCNA and clinicopathological parameters. Histopathology 2003; 43: 485–490.

5. . FIGO Oncology Committee. FIGO staging for gestational trophoblastic neoplasia 2000. Int J Gynecol Obstet 2002; 77: 285–287.

6. Menczer J, Schreiber L, Berger E, Golan A, Levy T. Assessment of Her-2/neu expression in hydatidiform moles for predic

7. Soper JT. Staging and evaluation of gestational trophoblastic disease. Clin Obstet Gynecol 2003; 46: 570–578. 8. Yazaki-Sun S, D

8. Yazaki-Sun S, Daher S, de Souza Ishigai MM, Alves MT, Mantovani TM, Mattar R. Correlation of c-erbB-2 oncogene and p53 tumor suppressor gene with malignant transformation of hydatidiform mole. J Obstet Gynaecol Res 2006; 32: 265–272.

9. Friedli M, Guipponi M, Bertrand S, et al. Identification of a novel member of the CLIC family, CLIC6, mapping to 21q22.12. Gene. 2003;320:31Y40.

10. Chen CD, Wang CS, Huang YH, et al. Overexpression of CLCI1 in human gastric carcinoma and its clinicopathological significance. Proteomics. 2007;7:155Y167.

2. Behtash N, Hasanzadeh M, Hanjani P. Complete remission of an unusual location of metastatic GTN: A case report. Cancer Ther 2005; 2: 575–577.

3. Makovitzky J, Radtke A, Shabani N, Friese K, Gerber B, Mylonas I. Invasive hydatidiform mole: Immunohistochemical labelling of inhibin/activin subunits, Ki67, p53 and glycodelin A in a rare case. Acta Histochem 2009; 111:360–365